Published in Blood on June 01, 1993
Benign monoclonal expansion of CD8+ lymphocytes in HIV infection. J Clin Pathol (2000) 0.98
Large granular lymphocytes are universally increased in human, macaque, and feline lentiviral infection. Vet Immunol Immunopathol (2015) 0.75
ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis (1999) 3.69
Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect (2004) 2.59
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia (2009) 2.30
Co-expression of myeloid antigens in childhood acute lymphoblastic leukaemia: relationship with the stage of differentiation and clinical significance. Br J Haematol (1991) 2.08
Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. Diabetologia (2006) 2.03
The translesion DNA polymerase zeta plays a major role in Ig and bcl-6 somatic hypermutation. Immunity (2001) 1.98
Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol (1997) 1.92
Endothelial progenitors in pulmonary hypertension: new pathophysiology and therapeutic implications. Eur Respir J (2010) 1.83
Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am J Pathol (2001) 1.63
Transient expression of type IV collagenolytic metalloproteinase by human mononuclear phagocytes. J Biol Chem (1986) 1.62
Knowledge and attitudes of Italian medical staff towards the approach and treatment of patients in pain. J Pain Symptom Manage (2001) 1.60
Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. J Immunol (1998) 1.56
Interferon alpha-2B and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial. Am J Med (1999) 1.55
Idiopathic thrombocytopenic purpura (ITP) in the elderly: clinical course in 178 patients. Eur J Haematol (2006) 1.50
Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis. Dig Dis Sci (1989) 1.47
Identification of NKp80, a novel triggering molecule expressed by human NK cells. Eur J Immunol (2001) 1.46
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med (1994) 1.41
Reactivation of oral-lingual herpes by chlorinated swimming pool water: a case report. Cutis (1995) 1.38
Activated T cells with immunoregulatory functions at different sites of involvement in sarcoidosis. Phenotypic and functional evaluations. Ann N Y Acad Sci (1986) 1.30
A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur J Immunol (1996) 1.29
High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS (1994) 1.29
Redistribution of T lymphocytes in the lymph nodes of patients with sarcoidosis. N Engl J Med (1982) 1.28
CXC chemokines IP-10 and mig expression and direct migration of pulmonary CD8+/CXCR3+ T cells in the lungs of patients with HIV infection and T-cell alveolitis. Am J Respir Crit Care Med (2000) 1.27
Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia. Leukemia (2009) 1.25
Vascular network changes in the retina with age and hypertension. J Hypertens (1995) 1.25
CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies. Mod Pathol (1999) 1.23
Immunohistochemical analysis of sarcoid granulomas. Evaluation of Ki67+ and interleukin-1+ cells. Am J Pathol (1988) 1.23
Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J Immunol (1996) 1.21
Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia (2007) 1.21
Microsatellite instability is associated with the histological features of the tumor in nonfamilial colorectal cancer. Cancer Res (1996) 1.20
Bronchoalveolar lavage and lung histology. Comparative analysis of inflammatory and immunocompetent cells in patients with sarcoidosis and hypersensitivity pneumonitis. Am Rev Respir Dis (1985) 1.18
The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. Eur J Immunol (1998) 1.17
Induction of Ig somatic hypermutation and class switching in a human monoclonal IgM+ IgD+ B cell line in vitro: definition of the requirements and modalities of hypermutation. J Immunol (1999) 1.17
Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by oncogenic signaling pathways. Leukemia (2012) 1.16
New pathogenetic insights into the sarcoid granuloma. Curr Opin Rheumatol (2000) 1.16
Retinal vascular network architecture in low-birth-weight men. J Hypertens (1997) 1.15
Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo. J Immunol (1999) 1.15
The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions. Cancer (1987) 1.15
Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood (1997) 1.14
B cell receptor engagement and T cell contact induce Bcl-6 somatic hypermutation in human B cells: identity with Ig hypermutation. J Immunol (2000) 1.12
Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis. J Clin Immunol (1988) 1.10
Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease. Br J Cancer (1987) 1.09
The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis. J Clin Invest (1999) 1.09
"The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med (1995) 1.08
Environmental signals influencing expression of the IFN-gamma receptor on human T cells control whether IFN-gamma promotes proliferation or apoptosis. J Immunol (1994) 1.06
CD8+ T lymphocytes in the lung of acquired immunodeficiency syndrome patients harbor human immunodeficiency virus type 1. Blood (1995) 1.05
Unusual malignant tumours in 49 patients with HIV infection. AIDS (1989) 1.04
Evidence of cells bearing interleukin-2 receptor at sites of disease activity in sarcoid patients. Clin Exp Immunol (1984) 1.03
Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease. Am J Respir Crit Care Med (1996) 1.03
HIV-1 and the lung. Infectivity, pathogenic mechanisms, and cellular immune responses taking place in the lower respiratory tract. Am Rev Respir Dis (1993) 1.02
Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party. Ann Oncol (2011) 1.02
First report of the Italian register for diffuse infiltrative lung disorders (RIPID). Monaldi Arch Chest Dis (2001) 1.01
Extracorporeal photochemotherapy may improve outcome in children with acute GVHD. Bone Marrow Transplant (2008) 1.01
Immunosuppressive therapy prevents recurrent pericarditis. J Am Coll Cardiol (1995) 1.01
Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma. Ann Oncol (2010) 1.01
Clonal studies of CD3- lymphoproliferative disease of granular lymphocytes. Blood (1993) 1.00
Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease. Br J Cancer (1984) 1.00
B cell activation during HIV-1 infection. II. Cell-to-cell interactions and cytokine requirement. J Immunol (1991) 1.00
MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias. Blood Cancer J (2011) 1.00
Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition. Cancer Res (1991) 0.99
Phenotypical and functional analysis of bronchoalveolar lavage lymphocytes in patients with HIV infection. Am Rev Respir Dis (1988) 0.99
An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy. Diabetologia (2013) 0.99
T-lymphocyte subpopulations in chronic lymphocytic leukemia: a quantitative and functional study. Cancer (1981) 0.99
Vitiligo and polyglandular autoimmune disease with autoantibodies to melanin-producing cells. A new syndrome? Arch Dermatol (1981) 0.99
Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia. Leukemia (2004) 0.99
PLZF-mediated control on VLA-4 expression in normal and leukemic myeloid cells. Oncogene (2006) 0.99
Immunophenotypic characterization of the cell infiltrate in five cases of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Hum Pathol (1992) 0.97
Oxaliplatin: available data in non-colorectal gastrointestinal malignancies. Crit Rev Oncol Hematol (2001) 0.97
Pulmonary alveolar macrophages in patients with sarcoidosis and hypersensitivity pneumonitis: characterization by monoclonal antibodies. J Clin Immunol (1987) 0.97
Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders. Blood (1996) 0.97